Animab
Gent
About Animab
Animab is a biotechnology company specializing in proprietary technology that supports livestock health. Animab combines cutting-edge research, animal science, and biotechnology to create products that improve animal health, reduce costs, and are more sustainable. Animab provides a safe and long-term solution for protecting piglets' intestinal health during the critical post-weaning stage. The antibodies in Animab are designed to mimic secretory IgA, a type of natural antibody that is passed through colostrum and milk to protect nursing animals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $15.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
- Website: animab.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Livestock
Social Profiles
Canonical: https://fsome.com/organization/animab-56390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.